Literature DB >> 19679135

Activation of purinergic receptors by ATP induces ventricular tachycardia by membrane depolarization and modifications of Ca2+ homeostasis.

Iman S Gurung1, Asli Kalin, Andrew A Grace, Christopher L-H Huang.   

Abstract

Cardiac myocytes are continuously exposed to extracellular nucleotides secreted by the myocytes themselves, nerve terminals, or platelets and other blood cells during coronary perfusion, and the concentrations of such extracellular nucleotides are known to increase during cardiac ischemia and hypoxia. The effects of the extracellular nucleotides ATP, ADP, UTP, and adenosine on ventricular arrhythmogenic properties were explored in 36 Langendorff-perfused mouse hearts using monophasic action potential recording. Extracellular nucleotides induced arrhythmic phenomena in form of ectopic activity and ventricular tachycardia in a potency order of ATP (n=7) > ADP (n=5) > UTP (n=3) approximately adenosine (n=3). The purinergic receptor antagonists suramin and pyridoxal phosphate-6-azo(benzene-2,4-disulphonic acid) reduced the incidence of ATP-triggered arrhythmias. In isolated ventricular myocytes, ATP induced sustained increases in diastolic Ca2+ and triggered multiple Ca2+ waves, which were inhibited by suramin but not by the L-type Ca2+ channel antagonist nifedipine. In whole-cell patch clamp experiments, extracellular ATP induced two distinct types of inward currents, which were inhibited by suramin and PPADS, suggesting activation of P2X receptors. ATP also induced delayed after-depolarizations and ectopic action potentials in current clamped ventricular myocytes. In conclusion, extracellular ATP activates purinergic receptors and induces arrhythmic activity through modifications of Ca2+ homeostasis and an activation of depolarizing membrane currents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679135     DOI: 10.1016/j.yjmcc.2009.08.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

1.  Pannexin 1 constitutes the large conductance cation channel of cardiac myocytes.

Authors:  Marie-Cecile Kienitz; Kirsten Bender; Rolf Dermietzel; Lutz Pott; Georg Zoidl
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 2.  Histochemistry and cell biology: the annual review 2010.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2011-01-29       Impact factor: 4.304

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

4.  Increased P2X7R expression in atrial cardiomyocytes of caveolin-1 deficient mice.

Authors:  K Barth; C Pfleger; A Linge; J A Sim; A Surprenant; N Steinbronn; R H Strasser; M Kasper
Journal:  Histochem Cell Biol       Date:  2010-06-19       Impact factor: 4.304

5.  Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activation.

Authors:  Elena Dolmatova; Gaelle Spagnol; Daniela Boassa; Jennifer R Baum; Kimberly Keith; Cinzia Ambrosi; Maria I Kontaridis; Paul L Sorgen; Gina E Sosinsky; Heather S Duffy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

6.  Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia.

Authors:  Iman S Gurung; Gema Medina-Gomez; Adrienn Kis; Michael Baker; Vidya Velagapudi; Sudeshna Guha Neogi; Mark Campbell; Sergio Rodriguez-Cuenca; Christopher Lelliott; Ian McFarlane; Matej Oresic; Andrew A Grace; Antonio Vidal-Puig; Christopher L-H Huang
Journal:  Cardiovasc Res       Date:  2011-06-01       Impact factor: 10.787

Review 7.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

8.  Platelets and cardiac arrhythmia.

Authors:  Jonas S S G de Jong; Lukas R C Dekker
Journal:  Front Physiol       Date:  2010-12-30       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.